dr perlmutter parkinsons treatment glutathione Initial management of Parkinson's disease Perlmutter Receives $3.2M to Study
Perlmutter Receives $3.2M to Study Parkinson's Disease Brain Inflammation Mallinckrodt Institute of Radiology WashU Medicine Perlmutter to conclude deanship in 2026 The Source WashU Frontiers The Therapeutic Potential of Metformin in Neurodegenerative Diseases Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives ACS Omega Development of immunotherapy and nanoparticles based strategies for the treatment of Parkinson's disease Journal of Pharmaceutical Investigation Springer Nature Link
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2




